Kirkland Advises Cinven and Bioclinica on Merger with ERT

Kirkland & Ellis advised international private equity firm Cinven and its portfolio company Bioclinica, a leading integrated solutions provider of clinical life science and technology expertise, on the merger of Bioclinica with ERT, a global leader in clinical end-point data solutions. As part of the transaction, Cinven will become a significant minority shareholder of ERT working in partnership with Nordic Capital, Astorg and Novo Holdings A/S. Financial terms of the transaction were not disclosed.

Read the press release from Cinven 

The Kirkland team was led by transactional partner Laura Sullivan, and included transactional partner Sean Rodgers and associates Brooke Coghlan, Amanda Gottlieb and Alan Heisman, tax partners Sara Zablotney and Vivek Ratnam, debt finance partner Jud Oswald and antitrust partners Matt Reilly and Mike DeRita and associate Sam Morelli.